Page 718 - WSAVA2017
P. 718

An Urban Experience
WSVA7-0187
CRITICAL CARE AND EMERGENCY MEDICINE
EVALUATION OF CONTINUOUS POSITIVE AIRWAY PRESSURE (CPAP), IN DOGS WHIT CARDIOGENIC PULMONARY OEDEMA SECONDARY TO SEVERE METAL VALVE DISEASE
P.M. Rocchi1, F.S. Greco1, A. Ruggeri1, C. Letizia1, S. Lugetti1, E. Cardone1
1Gregorio VII Veterinary Hospital, ICU, rome, Italy
Introduction
The aim of the study was to evaluate the application
and survival of continuous positive airway pressure (CPAP) compared to flow-by oxygen therapy, in dogs with cardiogenic pulmonary oedema (CPO) secondary to severe mitral valve disease (MVD).
Objectives
In this retrospective study, the diagnosis of CPO was performed according to the clinical findings: thoracic radiographs, echocardiography, arterial blood gas analysis. All dogs had diagnosis of MVD, and were treated with furosemide, pimobendan, butorphanol. Dogs were divided into 2 groups, one received treatment with CPAP; the other group received oxygen flow-by. Treatment with CPAP was continued intermittently while oxygen treatment by flow-by was continuously provided.
WSVA7-0197
CRITICAL CARE AND EMERGENCY MEDICINE
EVALUATION OF CONTINUOS POSITIVE AIRWAY PRESSURE (CPAP) IN CANINE RESPIRATORY FAILURE DERIVED FROM CARDIOGENIC AND NON CARDIOGENIC PULMONARY OEDEMA.
P.M. Rocchi1, E. Cardone2, L. Cagnazzo1, S. Lugetti1, A. Ruggeri2, F.S. Greco2
1Rome, Italy 2ICU, Rome, Italy
Introduction
The aim was to evaluate the tolerability and outcome
of CPAP, in respiratory failure derived from cardiogenic (CPO) and non cardiogenic pulmonary oedema (nCPO).
Objectives
This is a retrospective study. Dogs admitted and subsequently diagnosed with pulmonary oedema based on clinical findings, thoracic radiographs and ultra-sound, blood gas analysis were enrolled in the study. All dogs received treatment with CPAP. Treatment was continued intermittently.
Methods
In 12 months, 40 dogs were enrolled, 15 dogs had CPO, 25 dogs nCPO
Results
Dogs with CPO had a median age of 11y, median weight of 8kg. Fourteen dogs had severe mitral valve disease,
1 dog dilated cardiomyopathy. The duration of CPAP treatment decreased with improving clinical findings, averaged 15.6 h/day for 2,6 days. In 85% clinical parameters (RR, blood gas analysis) improved with 30 minutes of treatment, radiographic signs improved with median of 8h treatment. The mortality rate was 40%. Dogs with nCPO had a median age 9y, median weight 12kg. Ten dogs were diagnosed with ALI/ARDS, 6 dogs with brachycephalic syndrome, 9 dogs with primary pulmonary hypertension. Forty percent of dogs showed improvement in clinical parameters (RR, blood gas analysis) with median of 30min of treatment, 44% of dogs showed no improvement. Treatment was median 22 h/day for 2.2days. The mortality rate was 63%. All dogs tolerated CPAP.
Conclusions
Respiratory failure due to pulmonary oedema is common. In this study CPAP was a good alternative to other oxygen delivery modalities; CPAP was well tolerated with a favouarble outcome in patients with CPO.
    718
Methods
In 12 months, 30 dogs were enrolled: 14 dogs had CPAP helmet, 16 dogs had oxygen flow-by.
Results
In CPAP group the median age was 12.5y, median weight 6 kg. In 78% dogs, RR, respiratory work, arterial blood gas, parameters improved with 30 minutes of treatment, radiographic signs improved with median of 8 hours. Median wearing CPAP-helmet was 13.4h/day for 2,2 days. Mortality rate was 35%. All 14 dogs well tolerated helmet interfaces. In second group median age was 11.3y, median weight 8 kg. In 43% dogs
RR, respiratory work, arterial blood gas parameters improved with 30 minutes of oxygen flow-by. Mortality rate was 62%.
Conclusions
Respiratory failure due to CPO secondary to MVD is very common in dogs; in our study, the helmet interface was a valid alternative to flow-by, well tolerate, with a good outcome in dogs with CPO.
 42ND WORLD SMALL ANIMAL VETERINARY ASSOCIATION CONGRESS AND FECAVA 23RD EUROCONGRESS
  





























































   716   717   718   719   720